|
CBX6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.875800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.522380E-02 |
| Normal-vs-Stage2 |
1.621390E-01 |
| Normal-vs-Stage3 |
4.579600E-03 |
| Normal-vs-Stage4 |
1.172490E-02 |
| Stage1-vs-Stage2 |
6.389600E-01 |
| Stage1-vs-Stage3 |
5.032000E-01 |
| Stage1-vs-Stage4 |
5.793000E-01 |
| Stage2-vs-Stage3 |
3.814400E-01 |
| Stage2-vs-Stage4 |
4.391000E-01 |
| Stage3-vs-Stage4 |
9.602800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.683940E-02 |
| Normal-vs-AfricanAmerican |
1.863150E-01 |
| Normal-vs-Asian |
2.054100E-02 |
| Caucasian-vs-AfricanAmerican |
7.567800E-01 |
| Caucasian-vs-Asian |
5.876200E-01 |
| AfricanAmerican-vs-Asian |
5.292800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.257100E-03 |
| Normal-vs-Female |
1.870310E-02 |
| Male-vs-Female |
1.835400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.720100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.863800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.803500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.811200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.576400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.823200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.737400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.296200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.724400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.333600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.483800E-01 |
| Classical-VS-Follicular |
1.344220E-02 |
| Classical-VS-Other |
5.918000E-02 |
| Classical-VS-Normal |
6.098000E-02 |
| Tall-VS-Follicular |
5.380800E-01 |
| Tall-VS-Other |
1.397640E-01 |
| Tall-VS-Normal |
2.493500E-02 |
| Follicular-VS-Other |
3.139000E-01 |
| Follicular-VS-Normal |
9.231400E-04 |
| Other-VS-Normal |
5.718700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.238500E-03 |
| Normal-vs-N1 |
3.343100E-03 |
| N0-vs-N1 |
2.681400E-01 |
|
|
